Skip to main content

Daniel Grosu

Daniel Grosu has joined Sequenom as senior vice president and chief medical officer. Most recently, he was at Illumina as VP of clinical development and medical affairs. He also was Illumina's first CMO. Grosu's prior experience includes stints at Siemens Medical Solutions, Bayer HealthCare Pharmaceuticals, and Johnson & Johnson. 

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.